Trius Therapeutics Added to the NASDAQ Biotechnology Index
Trius Reports First Quarter 2012 Financial Results
Trius to Present at May Investor Conferences
Skin and Soft Tissue Concentrations of Tedizolid in Health Adults, Derendorf et al.
Pulmonary Disposition of Tedizolid in Healthy Adult Volunteers, Nicolau et al.
Comparative In Vivo Efficacy of Tedizolid, Linezolid and Vancomycin for MRSA in a Mouse Pneumonia Model, Nicolau et al.